A critical discovery in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential malignant suppressor protein is frequently inactivated in many kinds of tumors, https://thebookmarknight.com/story21912688/mini-antibodies-reactivate-p53-the-promising-hope-for-malignant-therapy